Chronic Hepatitis C
Two models predict response to therapy in genotype 1 chronic hepatitis C
Published in Hepatitis Weekly, March 6th, 2006
"Early prediction of response to therapy in genotype 1 chronic hepatitis C is difficult. Two predictive models, a pretreatment scoring model (PreT-SM) and a fourth week of therapy scoring model (4w-SM) were constructed in a cohort of 104 patients from a single center (estimation cohort) and validated in a cohort of 141 patients from four independent centers (validation cohort)," wrote E. Martinez-Bauer and colleagues, IDIBAPS.
"Individual scores were calculated using variables independently...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-03-06)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Antioxidant supplementation may be warranted in acute or chronic hepatitis B - Hepatitis B Virus
HBV-HCV co-infections are associated with a complex spectrum of virological profiles - Hepatitis B Virus
Hepatitis B virus protein HBx interacts with the human transcription regulatory protein p120E4F - Hepatitis C Virus
HCV affects dendritic cell cytokine induction and T-cell stimulation - Hepatitis C Virus
Hepatitis C virus polyprotein translation is linked to polymerase function - Alcoholic Hepatitis
ADAMTS13 may contribute to multiorgan failure in alcoholic hepatitis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
